These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15487886)

  • 1. ASHP Therapeutic Position Statement on the Use of Low-Molecular-Weight Heparins for Adult Outpatient Treatment of Acute Deep-Vein Thrombosis.
    Am J Health Syst Pharm; 2004 Sep; 61(18):1950-5. PubMed ID: 15487886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient treatment of acute venous thromboembolic disease.
    Yusen RD; Gage BF
    Clin Chest Med; 2003 Mar; 24(1):49-61. PubMed ID: 12685056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism.
    Wells PS; Anderson DR; Rodger MA; Forgie MA; Florack P; Touchie D; Morrow B; Gray L; O'Rourke K; Wells G; Kovacs J; Kovacs MJ
    Arch Intern Med; 2005 Apr; 165(7):733-8. PubMed ID: 15824291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparins in the treatment of deep-vein thrombosis.
    Martineau P; Tawil N
    Ann Pharmacother; 1998 May; 32(5):588-98, 601. PubMed ID: 9606481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of deep vein thrombosis using low-molecular-weight heparins.
    Groce JB
    Am J Manag Care; 2001 Nov; 7(17 Suppl):S510-5; discussion S515-23. PubMed ID: 11732662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation.
    Huse DM; Cummins G; Taylor DC; Russell MW
    Am J Manag Care; 2002 Jan; 8(1 Suppl):S10-6. PubMed ID: 11822346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis.
    Dager WE; King JH; Branch JM; Chow SL; Ferrer RE; Pak S; Togioka PY; White RH
    Ann Pharmacother; 2005; 39(7-8):1182-7. PubMed ID: 15956232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economics of low-molecular weight heparins.
    Rutschmann OT; Matchar DB
    Am J Manag Care; 2000 Nov; 6(20 Suppl):S1054-65; quiz 1066-7. PubMed ID: 11484305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home versus in-patient treatment for deep vein thrombosis.
    Othieno R; Abu Affan M; Okpo E
    Cochrane Database Syst Rev; 2007 Jul; (3):CD003076. PubMed ID: 17636714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of tinzaparin sodium versus unfractionated heparin in the treatment of proximal deep vein thrombosis.
    Caro JJ; Getsios D; Caro I; O'Brien JA
    Pharmacoeconomics; 2002; 20(9):593-602. PubMed ID: 12141887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient outcomes and cost analysis associated with an outpatient deep venous thrombosis treatment program.
    Groce JB
    Pharmacotherapy; 1998; 18(6 Pt 3):175S-180S. PubMed ID: 9853912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient treatment of venous thromboembolism using low molecular weight heparins. An overview.
    Matsagas MI
    Int Angiol; 2004 Dec; 23(4):305-16. PubMed ID: 15767978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home versus in-patient treatment for deep vein thrombosis.
    Schraibman IG; Milne AA; Royle EM
    Cochrane Database Syst Rev; 2001; (2):CD003076. PubMed ID: 11406067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An outpatient program to treat deep venous thrombosis with low-molecular-weight heparin.
    Pearson SD; Blair R; Halpert A; Eddy E; Mckean S
    Eff Clin Pract; 1999; 2(5):210-7. PubMed ID: 10623053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Büller HR; Agnelli G; Hull RD; Hyers TM; Prins MH; Raskob GE
    Chest; 2004 Sep; 126(3 Suppl):401S-428S. PubMed ID: 15383479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cut DVT (deep vein thrombosis) treatment costs with outpatient program for low-molecular-weight heparin.
    Clin Resour Manag; 2000 Feb; 1(2):24-6, 17. PubMed ID: 11183279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evolution in the pharmacological treatment of venous thrombosis according to evidence-based medicine].
    Manganaro A; Giannino D; Lembo D; Bruni F; Consolo F
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):41-51. PubMed ID: 11253339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tinzaparin sodium: a low-molecular-weight heparin.
    Neely JL; Carlson SS; Lenhart SE
    Am J Health Syst Pharm; 2002 Aug; 59(15):1426-36. PubMed ID: 12166042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Outpatient treatment of deep vein thrombosis with low-molecular-weight heparins. Experience from an open, prospective study in daily practice].
    Heidenreich C; Hohmann V; Bramlage P
    Med Klin (Munich); 2009 Jan; 104(1):20-7. PubMed ID: 19142593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight heparin in outpatient treatment of DVT.
    Yeager BF; Matheny SC
    Am Fam Physician; 1999 Feb; 59(4):945-52. PubMed ID: 10068716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.